RxDoctor Payments Data

Larry Hughes, MD

Family Medicine · Hemet, CANPI 1417033291

Payments from drug & device makers

$1,075in general payments, 2019–2025

Across 58 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$136
  • AbbVie$128
  • GSK$118
  • Astellas Pharma US Inc$111
  • Johnson & Johnson$99
  • Novo Nordisk$86
  • plus $397 from 12 others

What the payments were for

  • Food & beverage$1,075100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,075 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$56,697
Medicare patients
153
Services billed
4,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban119$82,284
XareltoRivaroxaban40$36,385
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$23,445
JanuviaSitagliptin Phosphate16$18,980
JardianceEmpagliflozin25$17,026
VraylarCariprazine Hcl12$16,202
MyrbetriqMirabegron33$11,515
Testosterone28$10,380
Lantus SolostarInsulin Glargine,hum.Rec.Anlog64$7,874
Breo ElliptaFluticasone/Vilanterol13$7,522
Incruse ElliptaUmeclidinium Bromide15$5,432
Levothyroxine Sodium452$5,415
Humalog Kwikpen U-200Insulin Lispro13$5,037
Atorvastatin Calcium371$3,648
Albuterol Sulfate HfaAlbuterol Sulfate83$3,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$82,284119 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$118$36,40063 claims
Johnson & JohnsonXarelto$99$36,38540 claims
MerckJanuvia$14$18,98016 claims
Boehringer IngelheimJardiance$27$17,02625 claims
AbbVieVraylar$128$16,20212 claims
Astellas Pharma US IncMyrbetriq$111$11,51533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,533 family medicine providers in California.

Other family medicine in Hemet

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →